In silico identification of public neo-antigens in head and neck Cancer for T cell receptor Engineering: Targeting PI3KCA and TP53 missense mutations. Oral Oncol 2024 Sep;156:106947
Date
07/16/2024Pubmed ID
39009483DOI
10.1016/j.oraloncology.2024.106947Scopus ID
2-s2.0-85198374252 (requires institutional sign-in at Scopus site)Author List
Zenga J, Himburg HA, Wong SJ, Kearl T, Hematti P, Jin VX, Memon AA, Mathison AJ, Awan MJAuthors
Angela Mathison PhD Assistant Professor in the Surgery department at Medical College of WisconsinJoseph Zenga MD Associate Professor in the Otolaryngology department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Antigens, NeoplasmComputer Simulation
Head and Neck Neoplasms
Humans
Mutation, Missense
Receptors, Antigen, T-Cell
Tumor Suppressor Protein p53